Search - tctmd.com

Displaying 81 - 100 of 2400

Sort: Relevancy | Date

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

News Conference News TCT 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

October 30, 2016

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Presentation TCT 2016

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Christopher B. Granger

October 30, 2016

Acute Stroke Intervention: Case #2

Presentation TCT 2016

Acute Stroke Intervention: Case #2

Presenter: Zvonimir Krajcer, D. Christopher Metzger, Bernhard Reimers

October 30, 2016

Acute Stroke Intervention: Case #1

Presentation TCT 2016

Acute Stroke Intervention: Case #1

Presenter: Zvonimir Krajcer, D. Christopher Metzger, Nick Hopkins

October 30, 2016

Optimal Device Selection for Carotid Stenting

Presentation TCT 2016

Optimal Device Selection for Carotid Stenting

Presenter: Zvonimir Krajcer, D. Christopher Metzger, Rahul Sakhuja

October 30, 2016

Tips and Tricks for Use of Proximal Embolic Protection During Carotid Stenting: A Case Series

Presentation TCT 2016

Tips and Tricks for Use of Proximal Embolic Protection During Carotid Stenting: A Case Series

Presenter: Zvonimir Krajcer, D. Christopher Metzger

October 30, 2016

Direct Carotid Access During Acute Stroke Intervention

Presentation TCT 2016

Direct Carotid Access During Acute Stroke Intervention

Presenter: Zvonimir Krajcer, D. Christopher Metzger, Mark H. Wholey

October 30, 2016

Radial Access to Carotid Stenting

Presentation TCT 2016

Radial Access to Carotid Stenting

Presenter: Zvonimir Krajcer, D. Christopher Metzger, Sasko Kedev

October 30, 2016

PCI Pharmacotherapy Considerations in Patients With Complicating Co-morbidities (CKD, Liver Disease, ASA Allergy, Prior Stroke, Thrombocytopenia)

Presentation TCT 2016

PCI Pharmacotherapy Considerations in Patients With Complicating Co-morbidities (CKD, Liver Disease, ASA Allergy, Prior Stroke, Thrombocytopenia)

Presenter: Sorin J. Brener, Franz-Josef Neumann, Sunil V. Rao

October 30, 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

October 29, 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

Yael L. Maxwell

October 28, 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

FDA 批准 PFO 封堵器用于预防中风复发

Yael L. Maxwell

October 28, 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Daily News

Study Explores Possible Mechanism to Explain Air Pollution-CVD Link

October 27, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

October 24, 2016

News Daily News

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

October 19, 2016

News Daily News

Short Bouts of Atrial Tachyarrhythmia Do Not Worsen Prognosis, Study Suggests

October 19, 2016

News Daily News

Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge

October 18, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.